Trial Profile
Study of drug resistance virus in Sofosbuvir/ Ledipasvir combination therapy to genotype 1 chronic hepatitis
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2019
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 27 Dec 2019 Status changed from recruiting to suspended.
- 04 Sep 2015 New trial record